持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/11 | 8,890 | 8,950 | 8,860 | 8,940 | -20 | -0.2% | 19,700 |
2018/01/10 | 8,880 | 8,970 | 8,880 | 8,960 | +80 | +0.9% | 21,400 |
2018/01/09 | 8,850 | 8,880 | 8,790 | 8,880 | -10 | -0.1% | 33,400 |
2018/01/05 | 8,810 | 8,890 | 8,720 | 8,890 | +80 | +0.9% | 27,200 |
2018/01/04 | 8,710 | 8,810 | 8,700 | 8,810 | +180 | +2.1% | 19,200 |
2017/12/29 | 8,680 | 8,680 | 8,590 | 8,630 | -50 | -0.6% | 13,700 |
2017/12/28 | 8,780 | 8,790 | 8,650 | 8,680 | -100 | -1.1% | 16,300 |
2017/12/27 | 8,800 | 8,810 | 8,750 | 8,780 | +10 | +0.1% | 21,900 |
2017/12/26 | 8,740 | 8,780 | 8,700 | 8,770 | +100 | +1.2% | 23,300 |
2017/12/25 | 8,560 | 8,670 | 8,550 | 8,670 | +140 | +1.6% | 24,400 |
2017/12/22 | 8,480 | 8,530 | 8,430 | 8,530 | +60 | +0.7% | 29,100 |
2017/12/21 | 8,360 | 8,490 | 8,330 | 8,470 | +90 | +1.1% | 25,400 |
2017/12/20 | 8,290 | 8,410 | 8,290 | 8,380 | ±0 | ±0% | 13,000 |
2017/12/19 | 8,400 | 8,400 | 8,340 | 8,380 | -10 | -0.1% | 17,700 |
2017/12/18 | 8,380 | 8,410 | 8,330 | 8,390 | +70 | +0.8% | 20,500 |
2017/12/15 | 8,290 | 8,350 | 8,230 | 8,320 | +50 | +0.6% | 26,800 |
2017/12/14 | 8,300 | 8,380 | 8,200 | 8,270 | -10 | -0.1% | 37,000 |
2017/12/13 | 8,190 | 8,290 | 8,190 | 8,280 | +80 | +1% | 21,800 |
2017/12/12 | 8,170 | 8,230 | 8,150 | 8,200 | +40 | +0.5% | 18,400 |
2017/12/11 | 8,250 | 8,250 | 8,120 | 8,160 | -40 | -0.5% | 21,200 |
2017/12/08 | 8,040 | 8,290 | 8,040 | 8,200 | +10 | +0.1% | 48,800 |
2017/12/07 | 8,160 | 8,210 | 8,150 | 8,190 | +100 | +1.2% | 16,900 |
2017/12/06 | 8,180 | 8,250 | 8,070 | 8,090 | -60 | -0.7% | 32,900 |
2017/12/05 | 8,010 | 8,190 | 8,010 | 8,150 | +120 | +1.5% | 33,200 |
2017/12/04 | 8,170 | 8,200 | 8,010 | 8,030 | -60 | -0.7% | 42,400 |
2017/12/01 | 8,160 | 8,170 | 8,080 | 8,090 | -30 | -0.4% | 27,200 |
2017/11/30 | 8,020 | 8,150 | 7,980 | 8,120 | +100 | +1.2% | 40,900 |
2017/11/29 | 7,960 | 8,040 | 7,960 | 8,020 | +80 | +1% | 22,300 |
2017/11/28 | 7,920 | 7,990 | 7,910 | 7,940 | +60 | +0.8% | 31,600 |
2017/11/27 | 7,930 | 7,950 | 7,870 | 7,880 | +20 | +0.3% | 30,900 |
2017/11/24 | 7,930 | 7,950 | 7,860 | 7,860 | -160 | -2% | 47,500 |
2017/11/22 | 8,150 | 8,160 | 8,010 | 8,020 | -80 | -1% | 25,100 |
2017/11/21 | 7,980 | 8,150 | 7,980 | 8,100 | +130 | +1.6% | 30,000 |
2017/11/20 | 7,950 | 8,010 | 7,920 | 7,970 | -70 | -0.9% | 46,500 |
2017/11/17 | 8,170 | 8,240 | 8,030 | 8,040 | -150 | -1.8% | 62,300 |
2017/11/16 | 8,050 | 8,190 | 8,040 | 8,190 | +100 | +1.2% | 18,800 |
2017/11/15 | 8,140 | 8,200 | 8,080 | 8,090 | -150 | -1.8% | 35,600 |
2017/11/14 | 8,220 | 8,310 | 8,210 | 8,240 | +10 | +0.1% | 27,200 |
2017/11/13 | 8,270 | 8,270 | 8,200 | 8,230 | -10 | -0.1% | 11,500 |
2017/11/10 | 8,200 | 8,250 | 8,170 | 8,240 | -70 | -0.8% | 23,800 |
2017/11/09 | 8,320 | 8,390 | 8,260 | 8,310 | -10 | -0.1% | 44,300 |
2017/11/08 | 8,260 | 8,350 | 8,220 | 8,320 | +30 | +0.4% | 38,100 |
2017/11/07 | 8,240 | 8,300 | 8,170 | 8,290 | +90 | +1.1% | 30,500 |
2017/11/06 | 8,210 | 8,230 | 8,170 | 8,200 | -10 | -0.1% | 20,900 |
2017/11/02 | 8,300 | 8,300 | 8,170 | 8,210 | -90 | -1.1% | 31,000 |
2017/11/01 | 8,280 | 8,320 | 8,240 | 8,300 | +20 | +0.2% | 54,200 |
2017/10/31 | 8,790 | 8,790 | 8,220 | 8,280 | -550 | -6.2% | 109,400 |
2017/10/30 | 8,880 | 8,990 | 8,660 | 8,830 | +30 | +0.3% | 95,900 |
2017/10/27 | 8,690 | 8,830 | 8,690 | 8,800 | +80 | +0.9% | 22,700 |
2017/10/26 | 8,780 | 8,780 | 8,720 | 8,720 | -10 | -0.1% | 11,500 |
1801~
1850
件表示中 / 3708件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 294,000円 | +5.1% | -7.0% | 2.72% | 19.30倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 310,000円 | +7.9% | -3.3% | 2.58% | 8.62倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 216,500円 | +3.1% | -6.5% | 2.22% | 10.05倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,300円 | -2.4% | -52.3% | 3.90% | 17.51倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,500円 | +4.1% | -3.1% | 2.89% | 17.59倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム